Related Experiment Videos
Are antidepressant trials too short? A case report.
The Journal of Clinical Psychiatry
|January 1, 1986
Summary
For resistant depression, a 13-week treatment trial demonstrated a full patient response, suggesting current 4-6 week recommendations may be insufficient for optimal outcomes in some individuals.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Treatment-resistant depression (TRD) poses a significant clinical challenge.
- Standard treatment guidelines often recommend 4-6 weeks for initial antidepressant efficacy assessment.
- Individual patient variability necessitates exploring extended treatment durations.
Observation:
- A single case of a woman diagnosed with resistant depression is presented.
- The patient exhibited a complete response to antidepressant therapy.
- This response was observed after a treatment duration of 13 weeks.
Findings:
- The reported case suggests that a 13-week treatment period can be effective for certain patients with resistant depression.
- The findings challenge the adequacy of shorter, commonly recommended treatment trial durations for TRD.
- Extended treatment may be crucial for identifying treatment responders who do not show early efficacy.
Implications:
- Clinicians should consider longer treatment trials for patients with resistant depression who do not respond within the initial 4-6 weeks.
- Revising treatment guidelines to incorporate extended trial durations may improve patient outcomes in TRD.
- Further research is warranted to determine optimal treatment durations for diverse patient populations with depression.